Virgo K S, McKirgan L W, Caputo M C, Mahurin D M, Chao L C, Caputo N A, Naunheim K S, Flye M W, Gillespie K N, Johnson F E
Department of Surgery, St. Louis University Health Sciences Center, Missouri, USA.
Ann Surg. 1995 Dec;222(6):700-10. doi: 10.1097/00000658-199512000-00003.
The first objective was to identify variations in patient management practice patterns after potentially curative lung cancer surgery. Patient management practice patterns were expected to range from intensive follow-up to no active surveillance. The second objective was to measure whether intensity of follow-up was related to patient outcomes.
An 18-month retrospective analysis was conducted of 182 patients with low TNM stage (< or = IIIA) lung cancer who were surgically treated with curative intent over the 11-year period from 1982 through 1992 at the St. Louis Department of Veterans Affairs Medical Center.
Patients were followed for a mean of 3.3 years, until death or the end of the study. Analyses of diagnostic test and outpatient visit frequency distributions and cluster analyses facilitated the identification of 62 nonintensively followed patients and 120 intensively followed patients. Both groups were comparable at baseline, and there were no significant differences in patient outcomes attributable to intensity of follow-up. Intensively followed patients did, however, live an average of 192 days longer than nonintensively followed patients.
Significant variations in follow-up practice patterns can exist within a single health care facility. In this analysis, variations in test and visit frequency did not result in statistically significant differences in patient outcomes, though the survival difference between groups suggests that some benefit might exist. Only well-designed prospective trials are likely to answer the question of what constitutes optimal follow-up after potentially curative lung cancer treatment.
首要目标是确定潜在可治愈性肺癌手术后患者管理实践模式的差异。患者管理实践模式预计从强化随访到无主动监测。第二个目标是衡量随访强度是否与患者预后相关。
对1982年至1992年在圣路易斯退伍军人事务医疗中心接受根治性手术治疗的182例低TNM分期(≤IIIA期)肺癌患者进行了为期18个月的回顾性分析。
患者平均随访3.3年,直至死亡或研究结束。对诊断检查和门诊就诊频率分布的分析以及聚类分析有助于识别62例非强化随访患者和120例强化随访患者。两组在基线时具有可比性,随访强度对患者预后无显著差异。然而,强化随访患者的平均生存期比非强化随访患者长192天。
在单一医疗机构内,随访实践模式可能存在显著差异。在本分析中,检查和就诊频率的差异并未导致患者预后的统计学显著差异,尽管两组之间的生存差异表明可能存在一些益处。只有精心设计的前瞻性试验才可能回答潜在可治愈性肺癌治疗后最佳随访方式的问题。